TOP 5 MOST VIEWED ARTICLES
RECENT COMMENTS
Article type: Editorial
Keywords: men and cancer, EUROCARE-3, EUROCARE-4, .
This article has 0 comments
Men’s health matters too
Europe’s women are much more likely to survive a cancer diagnosis than their male counterparts. According to EUROCARE-4, after adjusting for age and casemix, 54.6% of the women diagnosed between 1995 and 1999 survived for at least five years, but only 44.8% of men. The gap is the more worrying because, while differences in survival rates between countries have shown a welcome decrease since EUROCARE-3 (patients diagnosed 1990–1994), the gender gap has remained exactly the same, at 11.4 percentage points.
» Kathy Redmond
To read the complete article please click on the pdf iconCOMMENTS (0)
When submitted, your comment will be moderated. Messages which may be considered defamatory, which incite hatred or contain foul or abusive language, or are gratuitously offensive, will not be published. Please ensure that your comments are concise and relevant to the topic in question. Off-topic comments and comments without a username will not be published.
ESO reserves the absolute right not to publish comments.
ESO reserves the absolute right not to publish comments.
CancerWorld invites you to visit:
ESO Established in 1982, a non-profit organisation exclusively dedicated to increasing the knowledge of health professionals in cancer care.
CancerWorld is a pioneering initiative of the European School of Oncology financially supported through Sharing Progress in Cancer Care, a collaborative programme between ESO and Amgen, AstraZeneca, Eisai, Eli Lilly, GlaxoSmithKline, Merck and Novartis.